BCG vaccination: Effects on the patterns of pediatric leprosy

Tanusree Sarkar1, Somenath Sarkar2, Aparesh Chandra Patra2

  • 1Department of Dermatology, Burdwan Medical College, Bankura, WB, India.

Insights

BCG vaccination may protect children against leprosy, reducing multibacillary cases. This study found a lower proportion of severe leprosy in vaccinated children, suggesting enhanced immunity.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Public health

Background:

  • Leprosy remains a significant public health issue in India's pediatric population.
  • Bacille Calmette-Guérin (BCG) vaccination is suspected to offer some protection against leprosy.

Purpose of the Study:

  • To investigate leprosy patterns in children under 12 years old.
  • To compare paucibacillary (PB) and multibacillary (MB) leprosy proportions in BCG-vaccinated versus unvaccinated children.

Main Methods:

  • A cross-sectional study was conducted on 137 leprosy patients under 12 years old in Eastern India.
  • Patient history and clinical examinations were used, including verification of BCG vaccination status via scar presence.
  • Data were analyzed to compare leprosy types between vaccinated and unvaccinated groups.

Main Results:

  • The majority of patients (71.53%) were aged 11-12 years; PB leprosy was more common than MB leprosy.
  • The PB to MB ratio was 5.3:1 in vaccinated children versus 1.2:1 in unvaccinated children.
  • A statistically significant lower proportion of MB leprosy was observed in the BCG-vaccinated group (p=0.0352).

Conclusions:

  • BCG vaccination may play a role in bolstering cell-mediated immunity (CMI) against leprosy.
  • The findings suggest a protective effect of BCG vaccination, particularly against more severe forms of leprosy.
Abstract